NeoRecormon is a clear, colourless solution for injection under the skin (subcutaneously) or into a vein (intravenously). It contains a hormone called epoetin beta, which stimulates the production of red blood cells. Epoetin beta is produced by a specialised genetic technology and works in exactly the same way as the natural hormone erythropoietin.
How is NeoRecormon used?
Treatment with NeoRecormon should be initiated by a doctor who has experience in the care of patients with the types of anemia that NoeRecormon is used to treat and prevent. The medicine can only be obtained with a prescription. If a patient has a chronic renal failure drug can be injected into a vein or under the skin, but it must be injected under the skin in premature babies and in the patient who is receiving chemotherapy should be injected under the skin. The patient who is going to have their blood extracted for their surgery should be injected in the vein. The frequency of injection, amount of dose and how long it is used to depending on why NeoRecormon is used, and are adjusted according to the patient’s response to treatment. For more details, see the package leaflet.
How does NeoRecormon Work?
the active substance in NeoRecormon, epoetin beta, is a copy of the human hormone called erythropoietin. Erythropoietin is produced by the kidneys and stimulates the production of red blood cells from the bone marrow. In patients receiving chemotherapy or with chronic renal failure, anemia can be caused by a lack of erythropoietin, or by the body not responding enough to the erythropoietin it has naturally. The epoetin beta in NeoRecormon works in the body in the same way as the natural hormone to stimulate red blood cell production.
NeoRecormon was more effective than a placebo at increasing hemoglobin levels in patients with various types of anemia, including those chronic renal failures.
NeoRecormon injections are used for:
- Treating symptomatic anaemia caused by chronic kidney disease (renal anaemia) in patients on dialysis, or not yet on dialysis.
- Preventing anaemia in premature infants (weighing 750 to 1500 g and born at less than 34 weeks).
- Treating anaemia with related symptoms in adult cancer patients receiving chemotherapy
- Treating people donating their own blood before surgery. The injections of epoetin beta will increase the amount of blood that can be taken from your body before surgery and given back during or after the operation (this is an autologous transfusion).
- feeling tired or lacking energy, looking pale; this may be due to changes in your blood iron levels. Your doctor may prescribe an iron supplement for you
- bleeding or bruising more easily
- swelling of the arms, feet or legs
- stinging around the injection area
- chest or throat infection, difficulty breathing, cough
- nausea and vomiting
- pain with urination or increased urgency and/or frequency of urination